Geron Corp

GERN Com Stk USD0.001
Create an alert
Sell$1.30
Buy$1.31
$0.06 (4.38%)
Last updated today at
Trade

Key metrics

Open$1.37
Previous close$1.37
Market cap$880.19m
P/E ratio-
Volume1,357,618
Dividend yield0.00%
EMS-

Company information

Geron Corporation is a commercial-stage biopharmaceutical company. The Company develops first-in-class telomerase inhibitor, RYTELO (imetelstat) for the treatment of adult patients with low- to intermediate-1 risk ...

  • LocationUnited States
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyUSD
  • Shares in issue642.47m
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Accounts to trade in

Explore the accounts you can trade this stock in.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.